Mark Liebow
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Genetic Associations and Epidemiology
-
- Lymphoma Diagnosis and Treatment
- Genetic factors in colorectal cancer
Papers in
-
- Lymphoma Diagnosis and Treatment 20
- Genetic factors in colorectal cancer 6
- Genetics 9
- Chronic Lymphocytic Leukemia Research 9
- Genetic Associations and Epidemiology 6
- Co-authors
- Zachary S. Fredericksen (18 shared papers)James R. Cerhan (21 shared papers)Susan L. Slager (20 shared papers)Alice H. Wang (14 shared papers)Thomas Matthew Habermann (17 shared papers)Timothy G. Call (15 shared papers)Julie M. Cunningham (10 shared papers)Stephen Maxted Ansell (12 shared papers)
- Journals
- Cancer Epidemiology Biomarkers & Prevention (6 papers)Mayo Clinic Proceedings (5 papers)Journal of General Internal Medicine (5 papers)Blood (4 papers)International Journal of Cancer (4 papers)
- Partner nations
- United StatesBelarusUnited Kingdom
In The Last Decade
Mark Liebow
64 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 131
- Genetics 474
- Pathology and Forensic Medicine 733
- Immunology 393
- Cancer Research 251
- Oncology 456
Countries citing papers authored by Mark Liebow
This map shows the geographic impact of Mark Liebow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Liebow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Liebow more than expected).
Fields of papers citing papers by Mark Liebow
This network shows the impact of papers produced by Mark Liebow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Liebow. The network helps show where Mark Liebow may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Liebow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 271 | |
| 2 | 2013 | 204 | |
| 3 | 2013 | 175 | |
| 4 | 2013 | 167 | |
| 5 | 2007 | 143 | |
| 6 | 2015 | 142 | |
| 7 | 2014 | 141 | |
| 8 | 2015 | 110 | |
| 9 | 2014 | 87 | |
| 10 | 2016 | 87 | |
| 11 | 2002 | 86 | |
| 12 | 2008 | 77 | |
| 13 | 2017 | 76 | |
| 14 | 2008 | 75 | |
| 15 | 2002 | 72 | |
| 16 | 2008 | 65 | |
| 17 | 2009 | 61 | |
| 18 | 2010 | 58 | |
| 19 | 2015 | 54 | |
| 20 | 2005 | 54 |
About Mark Liebow
Mark Liebow is a scholar working on Pathology and Forensic Medicine, Genetics, Genetics, Immunology and Cancer Research, having authored 65 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (9 papers), Genetic factors in colorectal cancer (6 papers), Genetic Associations and Epidemiology (6 papers), Immune Cell Function and Interaction (4 papers), Healthcare cost, quality, practices (4 papers), Innovations in Medical Education (4 papers) and Healthcare Policy and Management (4 papers). The work is most often cited by research in Genetics (474 citations), Pathology and Forensic Medicine (733 citations), Immunology (393 citations), Cancer Research (251 citations) and Oncology (456 citations). Mark Liebow has collaborated with scholars based in United States, Belarus and United Kingdom. Frequent co-authors include Zachary S. Fredericksen, James R. Cerhan, Susan L. Slager, Alice H. Wang, Thomas Matthew Habermann, Timothy G. Call, Julie M. Cunningham, Stephen Maxted Ansell, Maurits J. Wiersema and Eric S. Edell. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, Mayo Clinic Proceedings, Journal of General Internal Medicine, Blood and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.